Press Releases
NEWARK, Calif. (January 30, 2024) –
Introducing innovative tools combining proteomics and glycomics within the spatial context, overcoming previous challenges and advancing the possibilities for biopharma discovery.
Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, and Navinci Diagnostics, leader of innovative in situ proximity ligation assay-based solutions, today announced that they have signed an agreement…
NEWARK, Calif. (July 17, 2023) –
Acquisition expands customers’ ability to accelerate their advanced bioconjugate and payload delivery design innovation
Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, today announced the acquisition of Quanta BioDesign
NEWARK, Calif. (March 2, 2023) –
Acquisition contributes to long-term growth strategy of accelerating commercialization of innovative labeling and detection technologies
Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, today announced the acquisitions of
NEWARK, Calif. (August 2, 2022) – Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, announced today that it has achieved ISO 9001:2015 certification of its new facility in Newark, California. This designation, renewed in May 2022 when the company moved its headquarters and manufacturing facilities, certifies a high level of quality assurance and consistency and is particularly important for Vector Laboratories custom…
NEWARK, Calif. (July 26, 2022) –
Diverse and deep financial and commercial experience will help lead Vector Laboratories’ ongoing expansion strategy
Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced that Vatea Herman, CPA and Kenny Drew, MS joined the Executive Team as Chief Financial Officer and Vice President, Commercial, respectively. …
NEWARK, Calif. (July 19, 2022) –
Offers a new, promising frontier to advance research and exploration of diseased and healthy tissue
Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced the la…
NEWARK, Calif. (March 29, 2022) –
Woo bringing key manufacturing experience and turnaround time reductions to proteomic and glycomic-focused company
Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced that Kum Ming Woo has joined its executive…
BURLINGAME, Calif. (March 16, 2022) –
Relocation driven by increased demand for Vector Laboratories’ growing areas of focus, glycomics and proteomics
Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today opened its new facility in Newark, California, where it will relocate its corporate headquarters this year. The relocation i…
BURLINGAME, Calif. (February 2, 2022) –
Key appointment will support the company’s commercial growth plans to deliver proteomics and protein innovations worldwide
Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced the addition of Katy Miles to its Board of Dire…
BURLINGAME, Calif. (December 14, 2021) –
Mr. Morales’ decades of financial experience in the life sciences sector will drive Vector Laboratories’ ongoing expansion strategy
Vector Laboratories, the pioneer and leader in the development and manufacture of protein labeling and detection reagents for life sciences research, today announced that Mike Morales, …
BURLINGAME, Calif. (November 16, 2021) –
Vector Laboratories, the market leader in the development and manufacture of labeling and detection reagents for biomedical research, today announced that it has promoted Pamela James, Ph.D., to the position of Vice President, Product, effective immediately. Dr. James was previously Senior Director, R&D and Operations. In her new role, she will continue to oversee research …
BURLINGAME, Calif. (September 7, 2021) –
Vector Laboratories, the market leader in the development and manufacture of labeling and detection reagents for biomedical research, today announced that it has closed a $124 million cash buyout, backed by private equity firm Thompson Street Capital Partners to accelerate its expansion into protein detection. This new funding enables Vector Laboratories to embark upon an acqui…
BURLINGAME, Calif. (November 14, 2018) –
Vector Laboratories, a Maravai LifeSciences company and leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today that it has achieved ISO 9001:2015 certification. This new designation for the company certifies a high level of quality assurance and consistency and will be particularly important to Vector customers who …
BURLINGAME, Calif. (September 11, 2018) –
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow. VECTASHIELD Vibrance produces increased brightness over the entire visible spectrum, including far-red fluorophore…
BURLINGAME, Calif. (June 12, 2018) –
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, has launched a redesigned company website, with advanced navigation and added technical resources. Users can now easily access application workflows and tools to help them select the best product for their work.
The new site also delivers an i…
BURLINGAME, Calif. (March 22, 2018) –
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today the availability of its new five-part video training series on immunohistochemistry (IHC) online this week,
BURLINGAME, Calif. (November 13, 2017) –
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces the TrueVIEW™ Autofluorescence Quenching Kit, offering the first effective technique for removing unwanted fluorescence in formalin-fixed paraffin embedded (FFPE) tissue samples, blood cells and structural elements such as co…
BURLINGAME, Calif. (October 18, 2017) –
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today the availability of a new guide for the growing field of immunofluorescence (IF). This new 32-page resource covers all aspects of IF and its implementation, including history of the technique’s development, the IF workfl…
BURLINGAME, Calif. (October 10, 2017) –
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today that it has selected Brockville, Ontario-based MJSBioLynx as its exclusive distributor in Canada. MJSBioLynx specializes in providing high-quality products for life science researchers in protein chemistry, immunology, molecular biology a…
BURLINGAME, Calif. (October 3, 2017) –
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces the ImmPRESS™ Duet Double-Staining Polymer Kit for immunohistochemistry. The new kit delivers all the advantages of polymer stains including low background staining, high signal intensity and the elimination of off- target binding. The kit e…
BURLINGAME, Calif. (September 18, 2017) –
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, announces the publication of a new immunohistochemistry (IHC) guide, providing a comprehensive compilation of helpful tools for understanding and implementing IHC. This new 48-page guide focuses on all aspects of IHC and its implementatio…
BURLINGAME, Calif. (September 16, 2017) –
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, announces an exclusive distribution agreement with Shenzhen-based NeoBioscience Technology Company, a distributor of a broad range of high-quality research tools. Established in 2007, the company has offices in Shenzhen, Beijing, Shanghai…
BURLINGAME, Calif. (September 6, 2017) –
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces the VectaFluor™ Duet kit, offering convenient, ready-to-use immunofluorescence double labeling. This new kit is ideal for use on a wide range…
BURLINGAME, Calif. (September 5, 2016) –
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces a ready-to-use (RTU) animal-free blocking agent and diluent for cell- and tissue-based immunohistochemistry (IHC) and immunofluorescence. This new plant-based block is an alternative to widely used animal-based blocks such as s…
BURLINGAME, Calif. (June 15, 2016) –
Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces ImmPACT™ Vector® Red AP Substrate Kit, delivering a crisp red reaction product for studies involving immunohistochemistry, immunocytochemistry, immunofluorescence, in situ hybridization and blots. The most sensitive red alka…
BURLINGAME, Calif. (April 5, 2016) –
Maravai LifeSciences, a transformative company in the life science research market, announced today that it has acquired Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research. The acquisition fits with Maravai LifeSciences’ goal of creating a market-leading life science business by bringing…
